Moody’s affirms Yale New Haven Health’s ‘Aa3’ rating

Moody’s Investors Service affirmed the long-term underlying “Aa3” ratings of Yale New Haven (Conn.) Health, affecting $715 million of rated debt.

Advertisement

The rating reflects Moody’s expectation that the system will continue to enjoy its leading market position in Connecticut along with the strong brand recognition associated with Yale University. Yale New Haven Health not only has a broad reach for tertiary and quaternary patients throughout the state but has been expanding its presence through consolidation.

The rating outlook is stable.

More articles on healthcare finance:

A recession is coming: What it could mean for healthcare
CHS expects $900M gain from hospital divestitures in 2019
Pennsylvania hospital employees work without pay

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.